Quoin Pharmaceuticals Ltd. ADR Aktie
Quoin Pharmaceuticals (Symbol QNRX) (WKN A3DMEZ) is a publicly traded pharmaceutical company that specializes in developing and commercializing innovative therapeutics for a diverse range of medical conditions. Its skilled team of researchers and industry experts work tirelessly to identify and harness breakthrough technologies that can enhance patient outcomes, improve the overall healthcare landscape, and create sustainable shareholder value. Focused on addressing unmet medical needs and utilizing its unique expertise, Quoin Pharmaceuticals is committed to bringing transformative, life-changing medication to market. With its shares trading on the stock exchange, investors have the opportunity to support the cutting-edge research that drives the company's robust pipeline of promising treatments.
Was spricht für und gegen Quoin Pharmaceuticals Ltd. ADR in den nächsten Jahren?
Pro
Kontra
Rendite von Quoin Pharmaceuticals Ltd. ADR im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals Ltd. ADR | - | - | - | - | - | - | - |
| Medpace Holdings Inc | 2,23 % | 0,46 % | -0,40 % | 105,67 % | 32,92 % | 163,03 % | - |
| Galapagos N.V. | 1,20 % | -1,04 % | -11,19 % | -24,77 % | -28,19 % | -59,14 % | - |
| Taro Pharmaceutical Industries Ltd | - | 0,00 % | 1,55 % | 68,38 % | 4,79 % | -35,41 % | -59,15 % |
